July 2023

T2 Biosystems

T2 Biosystems

Sole Agent (ATM)

Canaccord Genuity Acts as Sole Agent to T2 Biosystems on its US$65 million At-the-Market Offering

More Like This

US$16m

December 2024

Markers Therapeutics

Lead Placement Agent (PIPE)
December 2024

Point of Care Network

Financial Advisor to Point of Care Network on its Sale to IQVIA
US$92m

December 2024

Candel Therapeutics

Joint Bookrunner (CMPO)

View all Healthcare transactions